Search results for "Structure-Activity Relationship"

showing 10 items of 743 documents

Co-regulator recruitment and the mechanism of retinoic acid receptor synergy.

2002

Crystal structure and co-regulator interaction studies have led to a general mechanistic view of the initial steps of nuclear receptor (NR) action. Agonist-induced transconformation of the ligand-binding domain (holo-LBD) leads to the formation of co-activator complexes, and destabilizes the co-repressor complexes bound to the ligand-free (apo) LBD. However, the molecular basis of retinoid-X receptor (RXR) 'subordination' in heterodimers, an essential mechanism to avoid signalling pathway promiscuity, has remained elusive. RXR, in contrast to its heterodimer partner, cannot autonomously induce transcription on binding of cognate agonists. Here we show that RXR can bind ligand and recruit co…

Protein ConformationReceptors Retinoic AcidPlasma protein bindingRetinoid X receptorLigandsNuclear Receptor Coactivator 2Structure-Activity RelationshipmedicineNuclear Receptor Co-Repressor 2Binding siteNuclear receptor co-repressor 2PhysicsMultidisciplinaryCell biologyDNA-Binding ProteinsRepressor ProteinsRetinoic acid receptorRetinoid X ReceptorsMechanism of actionBiochemistryNuclear receptorModels Chemicalembryonic structuresNuclear receptor coactivator 2medicine.symptomDimerizationProtein BindingTranscription FactorsNature
researchProduct

Two amino acid residues determine the low substrate affinity of human cationic amino acid transporter-2A.

2003

Mammalian cationic amino acid transporters (CAT) differ in their substrate affinity and sensitivity to trans-stimulation. The apparent Km values for cationic amino acids and the sensitivity to trans-stimulation of CAT-1, -2B, and -3 are characteristic of system y+. In contrast, CAT-2A exhibits a 10-fold lower substrate affinity and is largely independent of substrate at the trans-side of the membrane. CAT-2A and -2B demonstrate such divergent transport properties, even though their amino acid sequences differ only in a stretch of 42 amino acids. Here, we identify two amino acid residues within this 42-amino acid domain of the human CAT-2A protein that are responsible for the apparent low af…

Protein ConformationRecombinant Fusion ProteinsBlotting WesternGreen Fluorescent ProteinsMolecular Sequence DataGene ExpressionArginineTransfectionBiochemistryStructure-Activity RelationshipXenopus laevisExtracellularAnimalsHumansBiotinylationAmino acid transporterAmino Acid SequenceAmino AcidsCationic Amino Acid Transporter 2Molecular BiologyGlutathione Transferasechemistry.chemical_classificationBinding SitesSubstrate (chemistry)Biological TransportCell BiologyPhoto-reactive amino acid analogAmino acidTransmembrane domainLuminescent ProteinsS-tagchemistryBiochemistryMutagenesis Site-DirectedOocytesElectrophoresis Polyacrylamide GelFemaleIntracellularThe Journal of biological chemistry
researchProduct

Identification of Single Amino Acid Residues of Human IL-6 Involved in Receptor Binding and Signal Initiation

1996

The pleiotropic cytokine interleukin-6 (IL-6) has been predicted to be a protein with four antiparallel alpha-helices. On target cells, IL-6 interacts with a specific ligand binding receptor subunit (IL-6R), and this complex associates with the signal-transducing subunit gp130. Human IL-6 acts on human and murine cells, whereas murine IL-6 is only active on murine cells. The construction of chimeric human/murine IL-6 proteins has allowed us to define a region (residues 77-95, region 2c) within the human IL-6 protein that is important for IL-6R binding and a region (residues 50-55, region 2a2) that is important for IL-6R dependent gp130 interaction. Guided by sequence alignment and molecular…

Protein ConformationRecombinant Fusion ProteinsProtein subunitMolecular Sequence DataImmunologySequence alignmentPlasma protein bindingBiologyLigandsMiceStructure-Activity RelationshipProtein structureAntigens CDVirologyCytokine Receptor gp130AnimalsHumansPoint MutationAmino Acid SequenceAmino AcidsReceptorPeptide sequenceMembrane GlycoproteinsInterleukin-6Receptors InterleukinCell BiologyGlycoprotein 130Receptors Interleukin-6BiochemistryMutagenesis Site-DirectedSignal transductionSequence AlignmentProtein BindingSignal TransductionJournal of Interferon & Cytokine Research
researchProduct

Classes of non-conventional tetraspanins defined by alternative splicing

2019

AbstractTetraspanins emerge as a family of membrane proteins mediating an exceptional broad diversity of functions. The naming refers to their four transmembrane segments, which define the tetraspanins‘ typical membrane topology. In this study, we analyzed alternative splicing of tetraspanins. Besides isoforms with four transmembrane segments, most mRNA sequences are coding for isoforms with one, two or three transmembrane segments, representing structurally mono-, di- and trispanins. Moreover, alternative splicing may alter transmembrane topology, delete parts of the large extracellular loop, or generate alternative N- or C-termini. As a result, we define structure-based classes of non-con…

ProteomicsGene isoformRNA splicingTetraspaninslcsh:MedicineComputational biologyBiologyEndoplasmic ReticulumArticleStructure-Activity Relationship03 medical and health sciences0302 clinical medicineIsomerismHumanslcsh:ScienceGene030304 developmental biology0303 health sciencesMultidisciplinarylcsh:RAlternative splicingLipid microdomainMembrane ProteinsTransmembrane proteinAlternative SplicingMembrane protein030220 oncology & carcinogenesisMembrane topologyembryonic structureslcsh:QStructural biologyFunction (biology)Scientific Reports
researchProduct

Aza- and Azo-Stilbenes: Bio-Isosteric Analogs of Resveratrol

2020

Several series of natural polyphenols are described for their biological and therapeutic potential. Natural stilbenoid polyphenols, such as trans-resveratrol, pterostilbene and piceatannol are well-known for their numerous biological activities. However, their moderate bio-availabilities, especially for trans-resveratrol, prompted numerous research groups to investigate innovative and relevant synthetic resveratrol derivatives. This review is focused on isosteric resveratrol analogs aza-stilbenes and azo-stilbenes in which the C=C bond between both aromatic rings was replaced with C=N or N=N bonds, respectively. In each series, synthetic ways will be displayed, and structural sights will be…

PterostilbeneResearch groupsPharmaceutical ScienceReviewResveratrolStilbenoidAntioxidantsAnalytical Chemistrylcsh:QD241-44103 medical and health scienceschemistry.chemical_compound0302 clinical medicinelcsh:Organic chemistryDrug DiscoveryStilbenesPhysical and Theoretical Chemistryazo-stilbene030304 developmental biologyPiceatannol0303 health sciencesAza CompoundsMolecular Structurestructure-activity relationshipOrganic Chemistryfood and beveragesStereoisomerismbio-isosterismtrans-resveratrolCombinatorial chemistryaza-stilbenechemistryChemistry (miscellaneous)PolyphenolResveratrol030220 oncology & carcinogenesisMolecular MedicineAzo CompoundsMolecules
researchProduct

Novel ruthenium methylcyclopentadienyl complex bearing a bipyridine perfluorinated ligand shows strong activity towards colorectal cancer cells

2017

Three new compounds have been synthesized and completely characterized by analytical and spectroscopic techniques. The new bipyridine-perfluorinated ligand L1 and the new organometallic complex [Ru(η 5 -MeCp)(PPh 3 ) 2 Cl] (Ru1) crystalize in the centrosymmetric triclinic space group P1¯. Analysis of the phenotypic effects induced by both organometallic complexes Ru1 and [Ru(η 5 -MeCp)(PPh 3 )(L1)][CF 3 SO 3 ] (Ru2), on human colorectal cancer cells (SW480 and RKO) survival, showed that Ru2 has a potent anti-proliferative activity, 4–6 times higher than cisplatin, and induce apoptosis in these cells. Data obtained in a noncancerous cell line derived from normal colon epithelial cells (NCM46…

PyridinesApoptosisLigands01 natural sciencesBipyridinechemistry.chemical_compoundDrug DiscoverySelectivityta116Molecular StructureCancro colo-retalChemistryapoptosisCycloparaffinsGeneral Medicine3. Good healthRutheniumsyöpäsolutColorectal NeoplasmsSelectivitymedicine.drugStereochemistryCompostos organometálicoschemistry.chemical_elementAntineoplastic Agentscolorectal cancerTriclinic crystal systemorganometalliyhdisteet010402 general chemistryRutheniumStructure-Activity Relationshipohjelmoitunut solukuolemaCell Line TumorOrganometallic CompoundsmedicineHumansCell ProliferationPharmacologyCisplatinScience & TechnologyDose-Response Relationship DrugApoptose010405 organic chemistryLigandRuthenium methylcyclopentadienylOrganic Chemistryta1182selectivitykompleksiyhdisteetColorectal cancer0104 chemical sciencesperäsuolisyöpäApoptosisCell cultureDrug Screening Assays Antitumorruthenium methylcyclopentadienyl
researchProduct

Discovery of γ-secretase modulators with a novel activity profile by text-based virtual screening.

2012

We present an integrated approach to identify and optimize a novel class of γ-secretase modulators (GSMs) with a unique pharmacological profile. Our strategy included (i) virtual screening through application of a recently developed protocol (PhAST), (ii) synthetic chemistry to discover structure–activity relationships, and (iii) detailed in vitro pharmacological characterization. GSMs are promising agents for treatment or prevention of Alzheimer’s disease. They modulate the γ-secretase product spectrum (i.e., amyloid-β (Aβ) peptides of different length) and induce a shift from toxic Aβ42 to shorter Aβ species such as Aβ38 with no or minimal effect on the overall rate of γ-secretase cleavag…

PyridinesPyridonesMolecular Sequence DataPeptideComputational biologyCHO CellsBiochemistryStructure-Activity RelationshipAlzheimer DiseaseCricetinaeAnimalsHumansγ secretaseAmino Acid Sequencechemistry.chemical_classificationVirtual screeningActivity profileAmyloid beta-PeptidesChemistryGeneral MedicineIntegrated approachIn vitroMinimal effectDrug DesignMolecular MedicineAmyloid Precursor Protein SecretasesACS chemical biology
researchProduct

Pharmacological activity of new histamine analogues.

1974

PyridinesReceptors DrugImmunologyPharmacology toxicologyGuinea PigsMolecular ConformationPharmacologyIn Vitro TechniquesToxicologychemistry.chemical_compoundStructure-Activity RelationshipDogsIleumMedicineAnimalsPharmacology (medical)Heart AtriaPharmacologyAniline Compoundsbusiness.industryImidazolesBiological activityAcetylcholinechemistrybusinessHistamineHistamineMuscle ContractionAgents and actions
researchProduct

Synthesis and Biological Evaluation of 2-Amino-3-(3’,4’,5’-Trimethoxybenzoyl)-6-Substituted-4,5,6,7-Tetrahydrothieno[2,3-c]pyridine Derivatives as An…

2008

Microtubules are among the most successful targets of compounds potentially useful for cancer therapy. A new series of inhibitors of tubulin polymerization based on the 2-amino-3-(3,4,5-trimethoxybenzoyl)-4,5,6,7-tetrahydrothieno[b]pyridine molecular skeleton was synthesized and evaluated for antiproliferative activity, inhibition of tubulin polymerization, and cell cycle effects. The most promising compound in this series was 2-amino-3-(3,4,5-trimethoxybenzoyl)-6-methoxycarbonyl-4,5,6,7-tetrahydrothieno[b]pyridine, which inhibits cancer cell growth with IC(50)-values ranging from 25 to 90 nM against a panel of four cancer cell lines, and interacts strongly with tubulin by binding to the co…

PyridinesStereochemistryClinical BiochemistryPharmaceutical ScienceAntimitotic AgentsCrystallography X-RayBiochemistryChemical synthesisArticleInhibitory Concentration 50Structure-Activity Relationshipchemistry.chemical_compoundTubulinMicrotubuleDrug DiscoveryPyridineAnimalsStructure–activity relationshipCytotoxicityMolecular BiologyMolecular StructurebiologyBicyclic moleculeChemistryOrganic ChemistryTubulinbiology.proteinMolecular MedicineAntimitotic Agent
researchProduct

Synthesis, antiproliferative activity, and mechanism of action of a series of 2-{[2E]-3-phenylprop-2-enoylamino}benzamides

2011

Several new 2-{[(2E)-3-phenylprop-2-enoyl]amino}benzamides 12a–s and 17t–v were synthesized by stirring in pyridine the (E)-3-(2-R1-3-R2-4-R3-phenyl)acrylic acid chlorides 11c–k and 11t–v with the appropriate anthranilamide derivatives 10a–c or the 5-iodoanthranilic acid 13. Some of the synthesized compounds were evaluated for their in vitro antiproliferative activity against the full NCI tumor cell line panel derived from nine clinically isolated cancer types (leukemia, non-small cell lung, colon, CNS, melanoma, ovarian, renal, prostate and breast). COMPARE analysis, effects on tubulin polymerization in cells and with purified tubulin, and effects on cell cycle distribution for 17t, the mo…

Pyridinesmedicine.drug_classStereochemistryAntineoplastic AgentsCarboxamideChemical synthesisArticlePolymerizationInhibitory Concentration 50Structure-Activity RelationshipTubulinCell Line TumorDrug DiscoverymedicineHumansStructure–activity relationshiportho-AminobenzoatesCytotoxicity2-{[2E]-3-phenylprop-2-enoylamino}benzamides antimitotic agents cytotoxic activityPharmacologyDose-Response Relationship DrugbiologyChemistryTubulin ModulatorsCell CycleOrganic ChemistryGeneral MedicineCell cycleSettore CHIM/08 - Chimica FarmaceuticaTubulin ModulatorsTubulinAcrylatesMechanism of actionBiochemistryBenzamidesbiology.proteinDrug Screening Assays Antitumormedicine.symptom
researchProduct